Search
for
Sort by
Research 751–780 of 1000+
- Roles of Wnt7a in embryo development, tissue homeostasis, and human diseases
- Scalp cooling in the prevention of anthracycline-induced alopecia
- Giant Morpheaform Basal Cell Carcinoma Mimicking Scarring Alopecia: Exception Prone to Neglect
- 1421 Primary cutaneous diffuse large B-cell lymphoma–leg type masquerading as a mucocele
- Madarosis and facial keratinaceous spines
- Abstract P5-11-11: A phase I safety study of topical calcitriol (BPM31543) for the prevention of chemotherapy-induced alopecia (CIA)
- In vitro cytotoxicity of selenium on a human mammary tumor cell line: and the effect of dietary selenium and magnesium on tumor growth in vivo
- Suppression of mammary tumorigenesis in transgenic mice by the RXR-selective retinoid, LGD1069.
- Eyelash Preservation During Chemotherapy and Topical Prostaglandin Therapy
- 5116 Postmenopausal Hyperandrogenism due to Rare Ovarian Tumor
- 9243 Postmenopausal Hyperandrogenism due to Rare Ovarian Tumor
- 9243 Postmenopausal Hyperandrogenism due to Rare Ovarian Tumor
- 269 Scalp cooling for chemotherapy-induced alopecia in skin of color patients: An interventional study
- Monitoring chemotherapy‐induced alopecia with trichoscopy
- Phase I-II trial of weekly bicalutamide in men with high PSA and negative biopsy
- 18F-FDG PET Uptake in the Scalp After Platelet-Rich Plasma Therapy
- A phase I safety study of topical calcitriol (BPM 31543) for the prevention of chemotherapy-induced alopecia (CIA).
- Questions and Answers
- The Influence of Various Parameters on the Success of Sensor-Controlled Scalp Cooling in Preventing Chemotherapy-Induced Alopecia
- Screening: seeking a balance
- 2-Substituted 4-(Thio)chromenone 6-<i>O</i>-Sulfamates: Potent Inhibitors of Human Steroid Sulfatase
- Aldo-Keto Reductase (AKR) 1C3 inhibitors: a patent review
- 'Atrophic telogen effluvium' from cytotoxic drugs and a randomized controlled trial to investigate the possible protective effect of pretreatment with a topical vitamin D3 analogue in humans
- NDA Submission of Vepdegestrant (ARV-471) to U.S. FDA: The Beginning of a New Era of PROTAC Degraders
- Intravaginal Testosterone Improves Sexual Satisfaction and Vaginal Symptoms Associated With Aromatase Inhibitors
- One of These Things Is Not Like the Others: The Idea of Precedence in Health Technology Assessment and Coverage Decisions
- Enriching Proteolysis Targeting Chimeras with a Second Modality: When Two Are Better Than One
- Use of a Healthcare Claims Database for Post-Marketing Safety Assessments of Eribulin in Japan: A Comparative Assessment with a Prospective Post-Marketing Surveillance Study
- Docetaxel and permanent alopecia
- Female pattern hair loss possibly caused by tamoxifen: Androgen receptor expression in the outer root sheath in the affected area